Aug 24, 2026Withdrawn0001683168-26-006676
All companies
Trade Valion Bio Inc424B4May 13, 2024
VA
Valion Bio Inc
VBIOPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $2.68M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, sec-edgar, nasdaq
IPO Calendar · NasdaqIPO
VBIOPrice
$0.1209
24h
-1.39%
Valuation
$2.68M
24h volume
$1.58M
Type
IPO
Trade Valion Bio IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 1h ago
Valion Bio Inc IPO public float & lock-up
Public float and locked shares extracted from Valion Bio Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
6.18M
Public float
4.71M
Locked
1.47M
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001787740.
Revenue
—
Net income
-$8.88M
Gross margin
—
Cash
$12.65M
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross profit | — | $2K | $287K | $299K | -$38K |
| Operating income | -$7.9M | -$4.48M | -$8.25M | -$10.1M | -$5.63M |
| Net income | -$8.88M | -$5.66M | -$8.24M | -$10.1M | -$8.49M |
| R&D expense | $3.13M | $1.31M | $1.66M | $1.73M | $878K |
| Cash & equivalents | $12.65M | $2M | $3.4M | $3.52M | $12.98M |
| Total assets | $31.61M | $2.81M | $5.16M | $5.88M | $15.04M |
| Total liabilities | $7.44M | $272K | $1.58M | $2.25M | $1.76M |
| Shareholders' equity | $16.8M | $2.54M | $3.58M | $3.63M | $13.27M |
SEC IPO filings
WithdrawnEDGAR filings resolved from VBIO / CIK 0001787740.
Aug 12, 2026Effective9999999995-26-002641
Jul 17, 2026Filed0001683168-26-005613
Apr 15, 2026Effective9999999995-26-001207
424B3PROSPECTUS
Apr 15, 2026Final prospectus0001683168-26-003004
CORRESPfilename1.htm
Apr 13, 2026SEC correspondence0001683168-26-002870
Apr 13, 2026Confidential draft0001683168-26-002868
S-1FORM S-1
Apr 13, 2026Filed0001683168-26-002867
UPLOADfilename1.pdf
Apr 9, 2026SEC correspondence0000000000-26-003598
Apr 6, 2026Confidential draft0001683168-26-002695
424B3PROSPECTUS
Jan 20, 2026Final prospectus0001683168-26-000421
424B3PROSPECTUS
Jan 20, 2026Final prospectus0001683168-26-000420
Valion Bio Inc IPO — frequently asked questions
- When did Valion Bio Inc go public?
- Valion Bio Inc has already gone public and now trades publicly on Nasdaq under the ticker VBIO.
- Can I buy Valion Bio Inc stock?
- Yes — Valion Bio Inc is publicly traded on Nasdaq as VBIO. You can follow its live price, valuation and post-IPO performance above.
- What is Valion Bio Inc's valuation?
- Valion Bio Inc's most recent valuation tracked here is $2.68M, derived from live market prices.